SCOPUS 정보 검색 플랫폼

Journal of Molecular Neuroscience

Volumn 18, Issue 1-2, 2002, Pages 29-35

(N-stearyl, Norleucine17)VIPhybrid is a broad spectrum vasoactive intestinal peptide receptor antagonist

(4) Moody, Terry W a Jensen, Robert T b Fridkin, Mati c Gozes, Illana d

a NATIONAL CANCER INSTITUTE (United States)

b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES (United States)

c WEIZMANN INSTITUTE OF SCIENCE (Israel)

d TEL AVIV UNIVERSITY (Israel)

Author keywords

Antagonist; Binding; Cyclic AMP (cAMP); PACAP receptors; VIP receptors

Indexed keywords

CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; IODINE 125; PROTEIN PAC 1; RO 251553; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE ANTAGONIST; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2; VASOACTIVE INTESTINAL POLYPEPTIDE[1-7]GROWTH HORMONE RELEASING FACTOR[8-27][15 LYSINE 18 ARGININE 27 LEUCINE]; VASOACTIVE INTESTINAL POLYPEPTIDE[N STEARYL 17 NORLEUCINE]; ADCYAP1R1 PROTEIN, MOUSE; DIAGNOSTIC AGENT; HORMONE RECEPTOR; HYBRID PROTEIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR 1; PEPTIDE FRAGMENT; RADIOACTIVE IODINE; STEARYL NORLEUCINE(17) VASOACTIVE INTESTINAL PEPTIDE; STEARYL-NORLEUCINE(17)-VASOACTIVE INTESTINAL PEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; VIPR1 PROTEIN, MOUSE; VIPR2 PROTEIN, MOUSE;

ANIMAL CELL; CELL STRAIN 3T3; CHO CELL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; GENETIC TRANSFECTION; HYBRID; IC 50; MEMBRANE BINDING; NONHUMAN; RECEPTOR AFFINITY; ANIMAL; ARTICLE; BINDING COMPETITION; DOSE RESPONSE; GENETICS; HAMSTER; METABOLISM; MOUSE; PHYSIOLOGY; RADIOASSAY; UPREGULATION;

ANIMALIA;

3T3 CELLS; ANIMALS; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; IODINE RADIOISOTOPES; MICE; PEPTIDE FRAGMENTS; RADIOLIGAND ASSAY; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; RECEPTORS, PITUITARY HORMONE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; RECOMBINANT FUSION PROTEINS; UP-REGULATION; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0036009178 PISSN: 08958696 EISSN: None Source Type: Journal
DOI: 10.1385/JMN:18:1-2:29 Document Type: Article

Times cited : (24)

References (44)

1
- 0026593319
- Pituitary adenylate cyclase activating polypeptide (PACAP): Discovery and current status of research
- (1992) Reg. Peptides , vol.37 , pp. 287-303
- Arimura, A.¹

2
- 0028949426
- Design and development of a vasoactive intestinal peptide analog as a novel therapeutic for bronchial asthma
- (1995) Biopolymers , vol.37 , pp. 57-66
- Bolin, D.R.¹ Michelewsky, J.² Wasserman, M.A.³ O'Donnell, M.⁴

3
- 0029946930
- Vasoactive intestinal peptide (VIP)1 receptor. Three nonadjacent amino acids are responsible for species selectivity with respect to recognition of peptide histidine isoleucine
- (1996) J. Biol. Chem. , vol.271 , pp. 12795-12800
- Couvineau, A.¹ Rouyer-Fessard, C.² Maoret, J.J.³ Gaudin, P.⁴ Nicole, P.⁵ LaBurthe, M.⁶

4
- 0028261933
- A chimeric VIP-PACAP analogue but not VIP pseudopeptides function as VIP receptor antagonists
- (1994) Peptides , vol.15 , pp. 95-100
- Fishbein, J.A.¹ Coy, D.H.² Hocart, S.J.³

5
- 0031418036
- 1 receptor agonists
- (1997) Peptides , vol.18 , pp. 1539-1545
- Gourlet, P.¹ Vandermeers, A.² Vertongen, P.³

6
- 0031427346
- 1 receptor
- (1997) Peptides , vol.18 , pp. 1555-1560
- Gourlet, P.¹ DeNeef, P.² Cnuddle, J.³ Waelbroeck, M.⁴ Robberechts, P.⁵

7
- 0031687386
- Vasoactive intestinal peptide modification at position 22 allows discrimination between receptor subtypes
- (1998) Eur. J. Pharmacol. , vol.354 , pp. 105-111
- Gourlet, P.¹ Vandermeers, A.² Rathe, J.³

8
- 0030974306
- 2 receptor subclass
- (1998) Peptides , vol.18 , pp. 403-408
- Gourlet, P.¹ Vertongen, P.² Vandermeers, A.³

9
- 0032702416
- Pharmaceutical VIP: Prospects and problems
- (1999) Current Medicinal Chemistry , vol.6 , pp. 1019-1034
- Gozes, I.¹ Fridkin, M.² Hill, J.M.³ Brenneman, D.E.⁴

10
- 0028908048
- Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors
- (1995) J. Pharmacol. Exp. Ther. , vol.273 , pp. 161-167
- Gozes, I.¹ Lilling, G.² Glazer, R.³

11
- 0025832239
- An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system
- (1991) J. Pharm. Exp. Ther. , vol.257 , pp. 959-966
- Gozes, I.¹ McCune, S.K.² Jacobson, L.³

12
- 0031800131
- Regulation of neuroprotective action of vasoactive intestinal peptide in the murine developing brain by protein kinase C and mitogen-activated protein kinase cascades: In vivo and in vitro studies
- (1998) J. Neurochem. , vol.70 , pp. 2574-2584
- Gressons, P.¹ Marret, S.² Martin, J.L.³ Laquerriere, A.⁴ Lombet, A.⁵ Evrard, P.⁶

13
- 0026511295
- Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide
- (1992) Neuron , vol.8 , pp. 811-819
- Ishihara, T.¹ Shigemoto, R.² Mori, K.³ Takahashi, K.⁴ Nagata, S.⁵

14
- 0033951850
- Rat and guinea pig pancreatic acini possess both VIP(1) and VIP(2) receptors, which mediate enzyme secretion
- (2000) Am. J. Physiol. Gastrointest. Liver Physiol. , vol.278 , pp. G64-G74
- Itoh, T.¹ How, W.² Katsunjo, T.³

15
- 0034082782
- Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors and in response to acute intracranial injury
- (2000) Cell Tissue Res. , vol.300 , pp. 219-230
- Jaworski, D.M.¹

16
- 0022551233
- Secretin/VIP stimulated secretion of bombesin-like peptides from human small cell lung cancer
- (1986) Cancer Res. , vol.46 , pp. 1214-1218
- Korman, L.Y.¹ Carney, D.N.² Citron, M.L.³ Moody, T.W.⁴

17
- 0003118489
- In VIP, PACAP and related peptides
- A. Arimura and S.I. Said (eds)
- (1997) Ann. N.Y. Acad. Sci. , vol.805 , pp. 94-111
- LaBurthe, M.¹ Couvineau, A.² Gaudin, P.³ Maoret, J.J.⁴ Rouyer-Fessard, C.⁵ Nicole, P.⁶

18
- 0025649568
- Vasoactive intestinal polypeptide binds with high affinity to non-small cell lung cancer cells and elevates cAMP levels
- (1990) Peptides , vol.11 , pp. 1205-1210
- Lee, M.¹ Jensen, R.T.² Bepler, G.³ Korman, L.Y.⁴ Moody, T.W.⁵

19
- 0030786398
- PACAPhybrid antagonizes PACAP receptor splice variants
- (1997) Life Sci. , vol.61 , pp. 631-639
- Leyton, J.¹ Coelho, T.² Hida, T.³

20
- 0032513176
- PACAP(6-38) inhibits the growth of prostate cancer cell lines
- (1998) Cancer Let. , vol.125 , pp. 131-139
- Leyton, J.¹ Coelho, T.² Coy, D.H.³

21
- 0032699149
- PACAP receptors are present in breast cancer cells
- (1999) Breast Cancer Research and Treatment , vol.56 , pp. 177-186
- Leyton, J.¹ Purdom, S.² Cassibang, M.³

22
- 0028700369
- Inhibition of human neuroblastoma growth by a specific VIP antagonist
- (1995) J. Mol. Neurosci. , vol.5 , pp. 231-239
- Lilling, G.¹ Wollman, Y.² Goldstein, M.N.³

23
- 0027332401
- 2 receptor: Molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide
- (1993) FEBS Lett. , vol.334 , pp. 3-8
- Lutz, E.M.¹ Sheward, W.J.² West, K.M.³ Morrow, J.A.⁴ Harmar, A.J.⁵

24
- 0034680832
- Identification of an essential amino acid motif within the C terminus of the pituitary adenylate cyclase-activating polypeptide type I receptor that is critical for signal transduction but not for receptor internalization
- (2000) J. Biol. Chem. , vol.275 , pp. 36134-36142
- Lyu, R.M.¹ Germano, P.M.² Choi, J.K.³ Le, S.V.⁴ Pisegna, J.R.⁵

25
- 0032446459
- VIP and PACAP in the CNS: Regulators of glial energy metabolism and modulators of glutamatergic signaling
- (1997) Ann. N.Y. Acad. Sci. USA , vol.865 , pp. 213-225
- Magistretti, P.J.¹ Cardinaux, J.R.² Martin, J.L.³

26
- 0001123566
- Human small cell lung carcinoma inhibition by vasoactive intestinal peptide (VIP) and helodermin (Hd)
- (1993) Biomed. Res. , vol.13 , pp. 373-375
- Maruno¹ Said, S.I.²

27
- 0000297188
- VIP analogues inhibit small cell lung cancer growth
- (1993) Biomed. Research , vol.13 , pp. 131-136
- Moody, T.W.¹ Zia, F.² Goldstein, A.³

28
- 0027276302
- A VIP antagonist inhibits the growth of non-small cell lung cancer
- (1993) Proc. Natl. Acad. Sci. USA , vol.90 , pp. 4345-4349
- Moody, T.W.¹ Zia, F.² Brenneman, D.³ Fridkin, M.⁴ Davidson, A.⁵ Gozes, I.⁶

29
- 0033792032
- 2 receptor
- (2000) Peptides , vol.21 , pp. 1543-1549
- Moreno, D.¹ Gourlet, P.² DeNeef, J.³ Cnuddle, M.⁴ Waelbroeck, M.⁵ Robberecht, P.⁶

30
- 0034710788
- 1 receptor: Crucial role for VIP binding
- (2000) Biochem. Biophys. Res. Commun. , vol.276 , pp. 654-659
- Nicole, P.¹ Maoret, J.J.² Couvineau, A.³ Momany, F.A.⁴ LaBurthe, M.⁵

31
- 0026516701
- Vasoactive intestinal peptide: Autocrine growth factor in neuroblastoma
- (1992) Regulatory Peptides , vol.37 , pp. 213-226
- O'Dorisio, M.S.¹ Fleshman, D.J.² Qualman, S.J.³ O'Dorisio, T.M.⁴

32
- 0022445853
- 17] VIP
- (1986) Am. J. Physiol. , vol.250 , pp. G553-G557
- Pandol, S.J.¹ Dharmsathaphorn, K.² Schoeffield, M.S.³ Vale, W.⁴ Rivier, J.⁵

33
- 0027281138
- Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor
- (1993) Proc. Natl. Acad. Sci. USA , vol.90 , pp. 6345-6349
- Pisegna, J.R.¹ Wank, S.A.²

34
- 0028889369
- In vitro identificaiton of vasoactive intestinal peptide receptors in human tumors: Implication for tumor imaging
- (1995) J. Nucl. Med. , vol.36 , pp. 1846-1853
- Reubi, J.C.¹

35
- 0034499735
- In vitro evaluation of VIP/PACAP receptors in healthy and diseases human tissues
- (2000) Ann. N.Y. Acad. Sci. , vol.921 , pp. 1-25
- Reubi, J.D.¹

36
- 0014954352
- Polypeptide with broad biological activity: Isolation from the small intestine
- (1970) Science , vol.69 , pp. 1217-1218
- Said, S.I.¹ Mutt, V.²

37
- 0023543619
- High affinity binding of VIP to human lung cancer cell lines
- (1987) Peptides , vol.8 , pp. 1101-1106
- Shaffer, M.M.¹ Carney, D.N.² Korman, L.Y.³ Lebovic, G.S.⁴ Moody, T.W.⁵

38
- 0035846913
- 1 receptor second transmembrane helix are essential for ligand binding and signal transduction
- (2001) J. Biol. Chemn. , vol.276 , pp. 1084-1088
- Solano, R.M.¹ Langer, I.² Perret, J.³

39
- 0027240588
- Differential signal transduction by five splice variants of the PACAP receptor
- (1993) Nature , vol.365 , pp. 170-175
- Spengler, D.¹ Waeber, C.² Pantaloni, C.³

40
- 0032430945
- Maxadilan is a specific agonist and its deleted peptide (M65) is a specific antagonist for PACAP type 1 receptor
- (1997) Ann. N.Y. Acad. Sci. , vol.865 , pp. 253-258
- Uchida, D.¹ Tatsuno, I.² Tanaka, T.³

41
- 0034082474
- 1 selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition
- (2000) Br. J. Pharmacol. , vol.130 , pp. 819-826
- Van Rampelbergh, J.V.¹ Juarranz, M.G.² Perret, J.³

42
- 0021813720
- 2 as a VIP antagonist
- (1985) Endocrinology , vol.116 , pp. 2643-2649
- Waelbroeck, M.¹ Robberecht, P.² Coy, D.H.³ Camus, J.C.⁴ De Neef, P.⁵ Christophe, J.⁶

43
- 0029684332
- Breast cancer growth is inhibited by VIP hybrid, a synthetic VIP receptor antagonist
- (1996) Cancer Res. , vol.56 , pp. 3486-3489
- Zia, H.¹ Hida, T.² Jakowlew, S.³

44
- 0033629877
- 17)VIPhybrid inhibits the growth of pancreatic cancer cell lines
- (1999) Life Sci. , vol.66 , pp. 379-387
- Zia, H.¹ Leyton, J.² Casibang, M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.